Genmab reported DKK634M in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 36522M 332M
AstraZeneca AZN:LN 29528M 1571M
Bayer BAYN:GR € 44634M 2087M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Fresenius Medical Care FME:GR € 13659M 315.63M
Galapagos GLPG:NA € 24.05M 1.3M
Genmab GEN:DC DK 634M 218M
GlaxoSmithKline GSK:LN 22111M 11217M
GN Store Nord GN:DC DK 15526M 340M
Hikma Pharmaceutical HIK:LN 1.55B 705M
Insmed INSM:US $ 807.32M 534K
Lonza Group LONN:SW 2.4B 0
Merck MRK:GR € 11803M 1172M
Novartis NOVN:VX SF 31031M 244M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Seattle Genetics SGEN:US $ 0M 0M